Novartis India Renamed to Evonile Pharma Following MCA Approval
Novartis India Ltd 路 Others (Uncategorized) 路 01 Oct 2026, 9:56 pm
Novartis India Renamed to Evonile Pharma Following MCA Approval Novartis India Limited has officially changed its corporate name to "Evonile Pharma Limited" effective 1st Oct'26, following the receipt of a fresh Certificate of Incorporation from the Ministry of Corporate Affairs (MCA). The rebranding was executed after securing shareholder approval via a Special Resolution at the 78th Annual General Meeting on 24th Sep'26, along with requisite statutory approvals. Consequently, the company has amended the name clauses across its Memorandum of Association (MoA) and Articles of Association (AoA) to reflect the new corporate identity.
Original exchange filing (PDF)
More announcements from Novartis India Ltd
- Transcript of the Earnings Call held on Wednesday, November 04, 2026. 路 06 Nov 2026
- Submission of the Letter of Offer in connection with the proposed Rights Issue of the Partly Paid-up Equity Shares of the Company. 路 06 Nov 2026
- Intimation is hereby given that the record date for determining the rights entitlement for the Rights Issue of partly paid-up shares of the Company shall be Wednesday, November 11, 2026. 路 05 Nov 2026
- Outcome of the Board Meeting held today i.e. November 04, 2026 路 05 Nov 2026
- Outcome of the meeting of the Rights Issue Committee held today i.e. November 04, 2026 路 05 Nov 2026
- Intimation of the Audio Recording of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2026, held today i.e. on Wednesday, November 04, 2026. 路 04 Nov 2026
- Intimation of the Integrated Unaudited Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
- Press Release - Unaudited Financial Results for the quarter and half year ended September 30, 2026. 路 04 Nov 2026
